is semaglutide a compound drug FDA Warns on Certain Forms of Compounded Risks of compounded semaglutide products

Select FDA-approved GLP-1 prescriptions may be covered through Medicare Part D for certain medical conditions, such as Type 2 diabetes or sleep apnea

Discover the possibilities by scheduling a consultation

Although the recent approval of resmetirom shows promise, its long-term efficacy and economic feasibility remain unclear

They found that individuals with major depressive disorders (MDD) had lower levels of GLP-1 hormone in their blood compared to healthy controls, and that increasingly lower GLP-1 levels were associated with worsening depression and anxiety scores

Brighter, better days are ahead

Hair loss emerged as a concern in some participants, consistent with what researchers observe across the GLP-1 agonist class